TGFBR1 and neoplasm: YM155 significantly (P<0.05, n=7) prevented the tumorigenesis (Figure 4b and c) and reduced the tumor burden (Figure 4d) of Tgfbr1/Pten 2cKO mice compared with the vehicle-only group (n=6).